{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "26",
                "@timestamp": "2023-07-26T12:33:37.000037-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "06"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {"xocs:funding-agency-matched-string": "National Research Council of Thailand and Baiya Phytopharm Co., Ltd"},
            "xocs:funding-addon-generated-timestamp": "2023-04-05T07:19:03.440Z",
            "xocs:funding-text": "This study was supported by the National Research Council of Thailand and Baiya Phytopharm Co., Ltd, Bangkok, Thailand. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Plant-produced Pharmaceuticals"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "127835605"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947218089-eb62de3caac7b422fe49be3cc0834b7a-1",
                            "ce:source-text": "aCenter of Excellence in Plant-produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand",
                            "@dptid": "127835605"
                        },
                        "author": [
                            {
                                "ce:given-name": "Christine Joy I.",
                                "preferred-name": {
                                    "ce:given-name": "Christine Joy I.",
                                    "ce:initials": "C.J.I.",
                                    "ce:surname": "Bulaon",
                                    "ce:indexed-name": "Bulaon C.J.I."
                                },
                                "@author-instance-id": "OB2BibRecID-947218089-da60e733e6fd74671f13a1f5f3d09d2f-1",
                                "@seq": "1",
                                "ce:initials": "C.J.I.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bulaon",
                                "@auid": "57218530325",
                                "ce:indexed-name": "Bulaon C.J.I."
                            },
                            {
                                "ce:given-name": "Waranyoo",
                                "preferred-name": {
                                    "ce:given-name": "Waranyoo",
                                    "ce:initials": "W.",
                                    "ce:surname": "Phoolcharoen",
                                    "ce:indexed-name": "Phoolcharoen W."
                                },
                                "@author-instance-id": "OB2BibRecID-947218089-a5cd700d6ce032007b78ebe399a37ccf-1",
                                "@seq": "4",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Phoolcharoen",
                                "@auid": "26531746600",
                                "ce:indexed-name": "Phoolcharoen W."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacognosy and Pharmaceutical Botany"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "104425772"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947218089-eea3343377ef73f5faf361840c71bafb-1",
                            "ce:source-text": "bDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand",
                            "@dptid": "104425772"
                        },
                        "author": [
                            {
                                "ce:given-name": "Christine Joy I.",
                                "preferred-name": {
                                    "ce:given-name": "Christine Joy I.",
                                    "ce:initials": "C.J.I.",
                                    "ce:surname": "Bulaon",
                                    "ce:indexed-name": "Bulaon C.J.I."
                                },
                                "@author-instance-id": "OB2BibRecID-947218089-da60e733e6fd74671f13a1f5f3d09d2f-1",
                                "@seq": "1",
                                "ce:initials": "C.J.I.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bulaon",
                                "@auid": "57218530325",
                                "ce:indexed-name": "Bulaon C.J.I."
                            },
                            {
                                "ce:given-name": "Waranyoo",
                                "preferred-name": {
                                    "ce:given-name": "Waranyoo",
                                    "ce:initials": "W.",
                                    "ce:surname": "Phoolcharoen",
                                    "ce:indexed-name": "Phoolcharoen W."
                                },
                                "@author-instance-id": "OB2BibRecID-947218089-a5cd700d6ce032007b78ebe399a37ccf-1",
                                "@seq": "4",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Phoolcharoen",
                                "@auid": "26531746600",
                                "ce:indexed-name": "Phoolcharoen W."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "address-part": "Jiangsu",
                            "postal-code": "210061",
                            "@afid": "126194184",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "GemPharmatech Co."},
                                {"$": "Ltd"}
                            ],
                            "affiliation-id": {"@afid": "126194184"},
                            "@affiliation-instance-id": "OB2BibRecID-947218089-bc92bc2b2b3d8cff737428ac23c5926b-1",
                            "ce:source-text": "cGemPharmatech Co., Ltd, Nanjing, Jiangsu 210061, China"
                        },
                        "author": [{
                            "ce:given-name": "Hongyan",
                            "preferred-name": {
                                "ce:given-name": "Hongyan",
                                "ce:initials": "H.",
                                "ce:surname": "Sun",
                                "ce:indexed-name": "Sun H."
                            },
                            "@author-instance-id": "OB2BibRecID-947218089-4355df394ba5d4b48f906328a03ddd6f-1",
                            "@seq": "2",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sun",
                            "@auid": "58164414400",
                            "ce:indexed-name": "Sun H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10250",
                            "@afid": "126563806",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Baiya Phytopharm Co."},
                                {"$": "Ltd."}
                            ],
                            "affiliation-id": {"@afid": "126563806"},
                            "@affiliation-instance-id": "OB2BibRecID-947218089-ef98888a5a3869a4b360b3e9e98ad115-1",
                            "ce:source-text": "dBaiya Phytopharm Co., Ltd., Bangkok 10250, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Ashwini",
                            "preferred-name": {
                                "ce:given-name": "Ashwini",
                                "ce:initials": "A.",
                                "ce:surname": "Malla",
                                "ce:indexed-name": "Malla A."
                            },
                            "@author-instance-id": "OB2BibRecID-947218089-185212e5109e795a5a1d9aac780741e3-1",
                            "@seq": "3",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Malla",
                            "@auid": "57014728200",
                            "@orcid": "0000-0003-3490-0704",
                            "ce:indexed-name": "Malla A."
                        }]
                    }
                ],
                "citation-title": "Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL/6-hPD-1 mouse implanted with MC38 colon cancer",
                "abstracts": "© 2023The therapeutic blockade of inhibitory PD-1 signaling has emerged as an effective approach for cancer immunotherapy. Nivolumab (Opdivo®), a monoclonal antibody (mAb) targeting the PD-1 immune checkpoint, is approved for treatment of several cancer indications. It functions by blocking the PD-1-mediated T-cell inhibition thus reinstating anticancer immune responses. Tremendous advances in plant biotechnology offer an alternative and economical strategy to produce therapeutic mAbs for immune-based therapies. In this study, recombinant anti-PD-1 Nivolumab was produced in Nicotiana benthamiana and the plant-produced anti-PD-1 mAb was exploited for cancer treatment in syngeneic mice model C57BL/6 mice that were used to test the antitumor efficacy of plant produced Nivolumab, along with commercial Opdivo®. C57BL/6 syngeneic mice treated with plant produced anti-PD-1 mAb exhibited reduction in the growth of established MC38 tumors. The plant produced Nivolumab treatment showed 82.9% antitumor effect in decreasing the tumor volume along with 50% tumor-free mice, whereas Opdivo® showed 90.26% reduction in volume without any tumor-free mice. Finally, plant-derived anti-PD-1 therapy was also well tolerated in tumor-bearing mice that correlated with no significant body weight changes. Overall, our plant-produced Nivolumab elicits significant inhibition of tumor growth in vivo and provides a proof-of-concept for the production of immunotherapy targeting PD-1.",
                "correspondence": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10250",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Baiya Phytopharm Co."},
                                {"$": "Ltd."}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947218089-81602e7f829b3e9b6bfbcc9e51c907e1-1"
                        },
                        "person": {
                            "ce:given-name": "Ashwini",
                            "@author-instance-id": "OB2BibRecID-947218089-72dc6d626e96a0f3342a6b7fb6133c97-1",
                            "ce:initials": "A.",
                            "ce:surname": "Malla",
                            "ce:indexed-name": "Malla A."
                        }
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "postal-code": "10330",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Center of Excellence in Plant-produced Pharmaceuticals"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947218089-e659712f12fbf3b6fb9382421c3429f1-1"
                        },
                        "person": {
                            "ce:given-name": "Waranyoo",
                            "@author-instance-id": "OB2BibRecID-947218089-f22306b54ec42a7e621576f53f7172f1-1",
                            "ce:initials": "W.",
                            "ce:surname": "Phoolcharoen",
                            "ce:indexed-name": "Phoolcharoen W."
                        }
                    }
                ],
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Antitumor",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Immuno-oncology",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Immunomodulators",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Nivolumab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "PD-1",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Programmed cell death",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Protein therapeutics",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.journals.elsevier.com/biotechnology-reports/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Biotechnology Reports",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {"voliss": {"@volume": "38"}},
                    "@type": "j",
                    "sourcetitle": "Biotechnology Reports",
                    "publicationdate": {
                        "month": "06",
                        "year": "2023",
                        "date-text": "June 2023",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Biotechnol. Rep.",
                    "@country": "nld",
                    "issn": {
                        "$": "2215017X",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier B.V."},
                    "article-number": "e00794",
                    "@srcid": "21100324971"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "27",
                                    "classification-description": "Biophysics, Bioengineering and Medical Instrumentation"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "1305"},
                                {"$": "2402"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "BIOC"},
                                {"$": "IMMU"}
                            ]
                        }
                    ]},
                    "tradenamegroup": {"tradenames": {
                        "trademanuitem": {
                            "tradename": "opdivol",
                            "manufacturer": {
                                "@country": "usa",
                                "$": "Bristol"
                            }
                        },
                        "@type": "TNM"
                    }},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": {
                            "cas-registry-number": "946414-94-4",
                            "chemical-name": "nivolumab"
                        }
                    }},
                    "manufacturergroup": {"manufacturers": [
                        {
                            "@type": "MNF",
                            "manufacturer": {
                                "@country": "usa",
                                "$": "Bristol"
                            }
                        },
                        {
                            "@type": "MNV",
                            "manufacturer": [
                                {
                                    "@country": "gbr",
                                    "$": "Abcam"
                                },
                                {
                                    "@country": "usa",
                                    "$": "Carestream"
                                }
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "We would like to thank Professor Hugh Mason (Arizona State University) for providing geminiviral vectors.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "RMC"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "08",
                    "@timestamp": "BST 13:08:41",
                    "@year": "2023",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2023604182",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "947218089",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230290774",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20230882592",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "2023133497",
                            "@idtype": "RMC"
                        },
                        {
                            "$": "20231207813",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85151297119",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85151297119",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:pii": "S2215017X23000140",
                    "ce:ern": "pii:S2215017X23000140",
                    "ce:doi": "10.1016/j.btre.2023.e00794"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "83",
                "reference": [
                    {
                        "ref-fulltext": "Sung, H., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J. Clin. 71:3 (2021), 209\u2013249.",
                        "@reference-instance-id": "OB2BibRecID-947218089-a82cb8eea72c065b8a4cab3eae1f8eb6-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100345654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Sung",
                                    "ce:indexed-name": "Sung H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J. Clin."
                        },
                        "ce:source-text": "Sung, H., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J. Clin., 2021. 71(3): p. 209\u2013249."
                    },
                    {
                        "ref-fulltext": "Fantini, M., et al. Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas. Front Immunol, 8(1899), 2018.",
                        "@reference-instance-id": "OB2BibRecID-947218089-546e5e03d21b27f572da7fd4f650c664-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040061209",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "8",
                                "@issue": "1899"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Fantini",
                                    "ce:indexed-name": "Fantini M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Fantini, M., et al., Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas. Front Immunol, 2018. 8(1899)."
                    },
                    {
                        "ref-fulltext": "Chu, D.T., et al. Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications. Cells, 9(3), 2020, 563.",
                        "@reference-instance-id": "OB2BibRecID-947218089-0807d22ebc00d95db51f20605d8eb482-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102213117",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "563"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Chu",
                                    "ce:indexed-name": "Chu D.T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cells"
                        },
                        "ce:source-text": "Chu, D.T., et al., Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications. Cells, 2020. 9(3): p. 563."
                    },
                    {
                        "ref-fulltext": "Wang, X., Luo, D., Basilion, J.P., Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers. Cancers, 13(12), 2021 (Basel).",
                        "@reference-instance-id": "OB2BibRecID-947218089-4a15bed879f5a567c12309153473ddf3-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107950643",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "13",
                                "@issue": "12"
                            }},
                            "ref-text": "(Basel)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Luo",
                                    "ce:indexed-name": "Luo D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Basilion",
                                    "ce:indexed-name": "Basilion J.P."
                                }
                            ]},
                            "ref-sourcetitle": "Cancers"
                        },
                        "ce:source-text": "Wang, X., D. Luo, and J.P. Basilion, Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers. Cancers (Basel), 2021. 13(12)."
                    },
                    {
                        "ref-fulltext": "Huang, H., et al. It's getting hot in here: targeting cancer stem-like cells with hyperthermia. J. Stem Cell Transplant. Biol., 2(2), 2017, 113.",
                        "@reference-instance-id": "OB2BibRecID-947218089-4a311d5530fcf072f4c20d2f3f517656-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "It's getting hot in here: targeting cancer stem-like cells with hyperthermia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056031127",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "2"
                                },
                                "pagerange": {"@first": "113"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang H."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Stem Cell Transplant. Biol."
                        },
                        "ce:source-text": "Huang, H., et al., It's getting hot in here: targeting cancer stem-like cells with hyperthermia. J. Stem Cell Transplant. Biol., 2017. 2(2): p. 113."
                    },
                    {
                        "ref-fulltext": "Liu, D., et al. Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy. Theranostics 10:3 (2020), 1181\u20131196.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b935846d7c9f6366d54639713787db34-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077607338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "1181",
                                    "@last": "1196"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Theranostics"
                        },
                        "ce:source-text": "Liu, D., et al., Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy. Theranostics, 2020. 10(3): p. 1181\u20131196."
                    },
                    {
                        "ref-fulltext": "Drăgănescu, M., Carmocan, C., Hormone therapy in breast cancer. Chirurgia 112:4 (2017), 413\u2013417 (Bucur).",
                        "@reference-instance-id": "OB2BibRecID-947218089-20d563a4e0ccc16dba77a7a11e38c33a-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Hormone therapy in breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028734574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "112",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "413",
                                    "@last": "417"
                                }
                            },
                            "ref-text": "(Bucur)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Drăgănescu",
                                    "ce:indexed-name": "Draganescu M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Carmocan",
                                    "ce:indexed-name": "Carmocan C."
                                }
                            ]},
                            "ref-sourcetitle": "Chirurgia"
                        },
                        "ce:source-text": "Drăgănescu, M. and C. Carmocan, Hormone therapy in breast cancer. Chirurgia (Bucur), 2017. 112(4): p. 413\u2013417."
                    },
                    {
                        "ref-fulltext": "Pucci, C., Martinelli, C., Ciofani, G., Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience, 13, 2019, 961.",
                        "@reference-instance-id": "OB2BibRecID-947218089-a2b21669fc1c712462e3f3b350a51b20-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Innovative approaches for cancer treatment: current perspectives and new challenges"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076601105",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "961"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Pucci",
                                    "ce:indexed-name": "Pucci C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Martinelli",
                                    "ce:indexed-name": "Martinelli C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Ciofani",
                                    "ce:indexed-name": "Ciofani G."
                                }
                            ]},
                            "ref-sourcetitle": "Ecancermedicalscience"
                        },
                        "ce:source-text": "Pucci, C., C. Martinelli, and G. Ciofani, Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience, 2019. 13: p. 961."
                    },
                    {
                        "ref-fulltext": "Kruger, S., et al. Advances in cancer immunotherapy 2019 \u2013 latest trends. J. Exp. Clin. Cancer Res., 38(1), 2019, 268.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b30d5054080d50463ae2d38b603cfce4-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Advances in cancer immunotherapy 2019 \u2013 latest trends"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067621510",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "268"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kruger",
                                    "ce:indexed-name": "Kruger S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Exp. Clin. Cancer Res."
                        },
                        "ce:source-text": "Kruger, S., et al., Advances in cancer immunotherapy 2019 \u2013 latest trends. J. Exp. Clin. Cancer Res., 2019. 38(1): p. 268."
                    },
                    {
                        "ref-fulltext": "Conlon, K.C., Miljkovic, M.D., Waldmann, T.A., Cytokines in the treatment of cancer. J. Interferon Cytokine Res. 39:1 (2019), 6\u201321.",
                        "@reference-instance-id": "OB2BibRecID-947218089-aa253c039db410800ab9a4dedc4e00cc-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cytokines in the treatment of cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059829743",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "6",
                                    "@last": "21"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Conlon",
                                    "ce:indexed-name": "Conlon K.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Miljkovic",
                                    "ce:indexed-name": "Miljkovic M.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Waldmann",
                                    "ce:indexed-name": "Waldmann T.A."
                                }
                            ]},
                            "ref-sourcetitle": "J. Interferon Cytokine Res."
                        },
                        "ce:source-text": "Conlon, K.C., M.D. Miljkovic, and T.A. Waldmann, Cytokines in the treatment of cancer. J. Interferon Cytokine Res., 2019. 39(1): p. 6\u201321."
                    },
                    {
                        "ref-fulltext": "Stanculeanu, D.L., et al. Development of new immunotherapy treatments in different cancer types. J. Med. Life 9:3 (2016), 240\u2013248.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b23afa846adfa7bb28a1b8ece96ea712-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Development of new immunotherapy treatments in different cancer types"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85016404601",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "240",
                                    "@last": "248"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Stanculeanu",
                                    "ce:indexed-name": "Stanculeanu D.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Med. Life"
                        },
                        "ce:source-text": "Stanculeanu, D.L., et al., Development of new immunotherapy treatments in different cancer types. J. Med. Life, 2016. 9(3): p. 240\u2013248."
                    },
                    {
                        "ref-fulltext": "Esfahani, K., et al. A review of cancer immunotherapy: from the past, to the present, to the future. Curr. Oncol. 27:Suppl 2 (2020), S87\u2013S97.",
                        "@reference-instance-id": "OB2BibRecID-947218089-3607698efe7594c5d28531c6efed0bd1-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "A review of cancer immunotherapy: from the past, to the present, to the future"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084276519",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "S87",
                                    "@last": "S97"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Esfahani",
                                    "ce:indexed-name": "Esfahani K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr. Oncol."
                        },
                        "ce:source-text": "Esfahani, K., et al., A review of cancer immunotherapy: from the past, to the present, to the future. Curr. Oncol., 2020. 27(Suppl 2): p. S87\u2013S97."
                    },
                    {
                        "ref-fulltext": "Rezaei, N., et al. Introduction on cancer immunology and immunotherapy. Cancer Immunology: A Translational Medicine Context, 2020, Springer International Publishing, Cham, 1\u20139 N. Rezaei, Editor.",
                        "@reference-instance-id": "OB2BibRecID-947218089-a0c2e09ae041dc4b9b1d068d05f2308a-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Introduction on cancer immunology and immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85086204308",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "1",
                                "@last": "9"
                            }},
                            "ref-text": "Springer International Publishing Cham N. Rezaei, Editor.",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Rezaei",
                                    "ce:indexed-name": "Rezaei N."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunology: A Translational Medicine Context"
                        },
                        "ce:source-text": "Rezaei, N., et al., Introduction on cancer immunology and immunotherapy, in Cancer Immunology: A Translational Medicine Context, N. Rezaei, Editor. 2020, Springer International Publishing: Cham. p. 1\u20139."
                    },
                    {
                        "ref-fulltext": "Brahmer, J.R., Hammers, H., Lipson, E.J., Nivolumab: targeting PD-1 to bolster antitumor immunity. Future Oncol. 11:9 (2015), 1307\u20131326.",
                        "@reference-instance-id": "OB2BibRecID-947218089-17831170d38e9d7e01dbac282dafb972-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Nivolumab: targeting PD-1 to bolster antitumor immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929251102",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1307",
                                    "@last": "1326"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Brahmer",
                                    "ce:indexed-name": "Brahmer J.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Hammers",
                                    "ce:indexed-name": "Hammers H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lipson",
                                    "ce:indexed-name": "Lipson E.J."
                                }
                            ]},
                            "ref-sourcetitle": "Future Oncol."
                        },
                        "ce:source-text": "Brahmer, J.R., H. Hammers, and E.J. Lipson, Nivolumab: targeting PD-1 to bolster antitumor immunity. Future Oncol., 2015. 11(9): p. 1307\u20131326."
                    },
                    {
                        "ref-fulltext": "Fife, B.T., Bluestone, J.A., Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 224:1 (2008), 166\u2013182.",
                        "@reference-instance-id": "OB2BibRecID-947218089-e58408a90d7f8735f0c484cd54dcc856-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "49249089425",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "224",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "166",
                                    "@last": "182"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Fife",
                                    "ce:indexed-name": "Fife B.T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bluestone",
                                    "ce:indexed-name": "Bluestone J.A."
                                }
                            ]},
                            "ref-sourcetitle": "Immunol. Rev."
                        },
                        "ce:source-text": "Fife, B.T. and J.A. Bluestone, Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev., 2008. 224(1): p. 166\u2013182."
                    },
                    {
                        "ref-fulltext": "Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12:4 (2012), 252\u2013264.",
                        "@reference-instance-id": "OB2BibRecID-947218089-07563ead8642f171d160204465cafc83-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The blockade of immune checkpoints in cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84858766182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "252",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.M.",
                                "@_fa": "true",
                                "ce:surname": "Pardoll",
                                "ce:indexed-name": "Pardoll D.M."
                            }]},
                            "ref-sourcetitle": "Nat. Rev. Cancer"
                        },
                        "ce:source-text": "Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer, 2012. 12(4): p. 252\u2013264."
                    },
                    {
                        "ref-fulltext": "Zou, W., Chen, L., Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8:6 (2008), 467\u2013477.",
                        "@reference-instance-id": "OB2BibRecID-947218089-56431fb02eb28a4756e43c6a61934d0c-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Inhibitory B7-family molecules in the tumour microenvironment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "44349150012",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "467",
                                    "@last": "477"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Zou",
                                    "ce:indexed-name": "Zou W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen L."
                                }
                            ]},
                            "ref-sourcetitle": "Nat. Rev. Immunol."
                        },
                        "ce:source-text": "Zou, W. and L. Chen, Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol., 2008. 8(6): p. 467\u2013477."
                    },
                    {
                        "ref-fulltext": "Vinay, D.S., et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin. Cancer Biol. 35 (2015), S185\u2013s198 Suppl.",
                        "@reference-instance-id": "OB2BibRecID-947218089-aaa9d247566a28ce66cc85e7fbc5bfbc-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Immune evasion in cancer: mechanistic basis and therapeutic strategies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84926160709",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "S185",
                                    "@last": "s198"
                                }
                            },
                            "ref-text": "Suppl",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Vinay",
                                    "ce:indexed-name": "Vinay D.S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Semin. Cancer Biol."
                        },
                        "ce:source-text": "Vinay, D.S., et al., Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin. Cancer Biol., 2015. 35 Suppl: p. S185\u2013s198."
                    },
                    {
                        "ref-fulltext": "Murillo, O., et al. Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma. Clin. Cancer Res. 14:21 (2008), 6895\u20136906.",
                        "@reference-instance-id": "OB2BibRecID-947218089-8d46707638d98ce419caaf737b32bdc0-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "58149232585",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "21"
                                },
                                "pagerange": {
                                    "@first": "6895",
                                    "@last": "6906"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Murillo",
                                    "ce:indexed-name": "Murillo O."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin. Cancer Res."
                        },
                        "ce:source-text": "Murillo, O., et al., Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma. Clin. Cancer Res., 2008. 14(21): p. 6895\u20136906."
                    },
                    {
                        "ref-fulltext": "Melero, I., et al. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 7:2 (2007), 95\u2013106.",
                        "@reference-instance-id": "OB2BibRecID-947218089-4fa3bcd8d67adf86e947a80ef6a17174-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Immunostimulatory monoclonal antibodies for cancer therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33846465547",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "95",
                                    "@last": "106"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Melero",
                                    "ce:indexed-name": "Melero I."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Rev. Cancer"
                        },
                        "ce:source-text": "Melero, I., et al., Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer, 2007. 7(2): p. 95\u2013106."
                    },
                    {
                        "ref-fulltext": "Spain, L. and J. Larkin, Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma. 2016. 8(6): p. 677\u2013679.",
                        "@reference-instance-id": "OB2BibRecID-947218089-4d6543513cf6b574d333ffe5f8678ad0-21",
                        "@id": "21",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151281036",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "677",
                                "@last": "679"
                            }},
                            "ref-text": "Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma. 2016. 8(6):",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Spain",
                                    "ce:indexed-name": "Spain L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Larkin",
                                    "ce:indexed-name": "Larkin J."
                                }
                            ]}
                        },
                        "ce:source-text": "Spain, L. and J. Larkin, Weighing up the pros and cons of immune checkpoint inhibitors in the treatment of melanoma. 2016. 8(6): p. 677\u2013679."
                    },
                    {
                        "ref-fulltext": "Larkin, J., et al., Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. 2015. 373(1): p. 23\u201334.",
                        "@reference-instance-id": "OB2BibRecID-947218089-f7ba2eeb073937f8bd8f55bf0ffca0d5-22",
                        "@id": "22",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151293452",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "23",
                                "@last": "34"
                            }},
                            "ref-text": "Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. 2015. 373(1):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Larkin",
                                    "ce:indexed-name": "Larkin J."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Larkin, J., et al., Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. 2015. 373(1): p. 23\u201334."
                    },
                    {
                        "ref-fulltext": "Robert, C., et al., Pembrolizumab versus ipilimumab in advanced melanoma. 2015. 372(26): p. 2521\u20132532.",
                        "@reference-instance-id": "OB2BibRecID-947218089-127a11790c80f4acc15e8a72fdff075f-23",
                        "@id": "23",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151292197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "2521",
                                "@last": "2532"
                            }},
                            "ref-text": "Pembrolizumab versus ipilimumab in advanced melanoma. 2015. 372(26):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Robert",
                                    "ce:indexed-name": "Robert C."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Robert, C., et al., Pembrolizumab versus ipilimumab in advanced melanoma. 2015. 372(26): p. 2521\u20132532."
                    },
                    {
                        "ref-fulltext": "Chae, Y.K., Oh, M.S., Giles, F.J., Molecular biomarkers of primary and acquired resistance to T-cell-mediated immunotherapy in cancer: landscape, clinical implications, and future directions. Oncologist 23:4 (2018), 410\u2013421.",
                        "@reference-instance-id": "OB2BibRecID-947218089-c86180e04d89a4c1e70dae50fb0cde6c-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Molecular biomarkers of primary and acquired resistance to T-cell-mediated immunotherapy in cancer: landscape, clinical implications, and future directions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85038242683",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "410",
                                    "@last": "421"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Chae",
                                    "ce:indexed-name": "Chae Y.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Oh",
                                    "ce:indexed-name": "Oh M.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Giles",
                                    "ce:indexed-name": "Giles F.J."
                                }
                            ]},
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Chae, Y.K., M.S. Oh, and F.J. Giles, Molecular biomarkers of primary and acquired resistance to T-cell-mediated immunotherapy in cancer: landscape, clinical implications, and future directions. Oncologist, 2018. 23(4): p. 410\u2013421."
                    },
                    {
                        "ref-fulltext": "Hargadon, K.M., Johnson, C.E., Williams, C.J., Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors. Int. Immunopharmacol. 62 (2018), 29\u201339.",
                        "@reference-instance-id": "OB2BibRecID-947218089-f61e3f1c6e926f3add1e41d35e81aa88-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049351361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "29",
                                    "@last": "39"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hargadon",
                                    "ce:indexed-name": "Hargadon K.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson C.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Williams",
                                    "ce:indexed-name": "Williams C.J."
                                }
                            ]},
                            "ref-sourcetitle": "Int. Immunopharmacol."
                        },
                        "ce:source-text": "Hargadon, K.M., C.E. Johnson, and C.J. Williams, Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors. Int. Immunopharmacol., 2018. 62: p. 29\u201339."
                    },
                    {
                        "ref-fulltext": "Patel, B.A., Liu, S.V., Chapter 6 - lung adenocarcinoma: second-line treatment. Pulmonary Adenocarcinoma: Approaches to Treatment, 2019, Elsevier, 103\u2013114 L. HornEditor.",
                        "@reference-instance-id": "OB2BibRecID-947218089-de4e725a278cb3b682bad3711eef1e36-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Chapter 6 - lung adenocarcinoma: second-line treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089089893",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "103",
                                "@last": "114"
                            }},
                            "ref-text": "Elsevier L. HornEditor",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel B.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu S.V."
                                }
                            ]},
                            "ref-sourcetitle": "Pulmonary Adenocarcinoma: Approaches to Treatment"
                        },
                        "ce:source-text": "Patel, B.A. and S.V. Liu, Chapter 6 - lung adenocarcinoma: second-line treatment, in Pulmonary Adenocarcinoma: Approaches to Treatment, L. Horn, Editor. 2019, Elsevier. p. 103\u2013114."
                    },
                    {
                        "ref-fulltext": "Rajan, A., et al. Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: role in advanced cancers. Hum. Vaccin. Immunother. 12:9 (2016), 2219\u20132231.",
                        "@reference-instance-id": "OB2BibRecID-947218089-d00c4fe322a3f0703197aa7f3c3b3478-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: role in advanced cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84987816326",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "2219",
                                    "@last": "2231"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Rajan",
                                    "ce:indexed-name": "Rajan A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Hum. Vaccin. Immunother."
                        },
                        "ce:source-text": "Rajan, A., et al., Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: role in advanced cancers. Hum. Vaccin. Immunother., 2016. 12(9): p. 2219\u20132231."
                    },
                    {
                        "ref-fulltext": "Guo, L., Zhang, H., Chen, B., Nivolumab as programmed death-1 (PD-1) inhibitor for targeted immunotherapy in tumor. J. Cancer 8:3 (2017), 410\u2013416.",
                        "@reference-instance-id": "OB2BibRecID-947218089-edc2f4ee4035b0aeb95fd605b4925c8f-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Nivolumab as programmed death-1 (PD-1) inhibitor for targeted immunotherapy in tumor"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85012190987",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "410",
                                    "@last": "416"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Guo",
                                    "ce:indexed-name": "Guo L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen B."
                                }
                            ]},
                            "ref-sourcetitle": "J. Cancer"
                        },
                        "ce:source-text": "Guo, L., H. Zhang, and B. Chen, Nivolumab as programmed death-1 (PD-1) inhibitor for targeted immunotherapy in tumor. J. Cancer, 2017. 8(3): p. 410\u2013416."
                    },
                    {
                        "ref-fulltext": "Brahmer, J., et al., Nivolumab versus Docetaxel in Advanced Squamous-Cell Non\u2013Small-Cell Lung Cancer. 2015. 373(2): p. 123\u2013135.",
                        "@reference-instance-id": "OB2BibRecID-947218089-9b80d9e3dc47676bc390b099411b621f-29",
                        "@id": "29",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151236765",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "123",
                                "@last": "135"
                            }},
                            "ref-text": "Nivolumab versus Docetaxel in Advanced Squamous-Cell Non\u2013Small-Cell Lung Cancer. 2015. 373(2):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Brahmer",
                                    "ce:indexed-name": "Brahmer J."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Brahmer, J., et al., Nivolumab versus Docetaxel in Advanced Squamous-Cell Non\u2013Small-Cell Lung Cancer. 2015. 373(2): p. 123\u2013135."
                    },
                    {
                        "ref-fulltext": "Borghaei, H., et al., Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer. 2015. 373(17): p. 1627\u20131639.",
                        "@reference-instance-id": "OB2BibRecID-947218089-487c6723bf4fea3dedc24d906a8b798f-30",
                        "@id": "30",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151239438",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "1627",
                                "@last": "1639"
                            }},
                            "ref-text": "Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer. 2015. 373(17):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Borghaei",
                                    "ce:indexed-name": "Borghaei H."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Borghaei, H., et al., Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer. 2015. 373(17): p. 1627\u20131639."
                    },
                    {
                        "ref-fulltext": "Robert, C., et al., Nivolumab in previously untreated melanoma without BRAF mutation. 2014. 372(4): p. 320\u2013330.",
                        "@reference-instance-id": "OB2BibRecID-947218089-c5bc806eb87de7e5e9dfd5a239965a2e-31",
                        "@id": "31",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151261242",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "320",
                                "@last": "330"
                            }},
                            "ref-text": "Nivolumab in previously untreated melanoma without BRAF mutation. 2014. 372(4):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Robert",
                                    "ce:indexed-name": "Robert C."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Robert, C., et al., Nivolumab in previously untreated melanoma without BRAF mutation. 2014. 372(4): p. 320\u2013330."
                    },
                    {
                        "ref-fulltext": "Wang, C., et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol. Res. 2:9 (2014), 846\u2013856.",
                        "@reference-instance-id": "OB2BibRecID-947218089-e3316c2574fb16534703b7f319255ae3-32",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84920031180",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "846",
                                    "@last": "856"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol. Res."
                        },
                        "ce:source-text": "Wang, C., et al., In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol. Res., 2014. 2(9): p. 846\u201356."
                    },
                    {
                        "ref-fulltext": "Tartari, F., et al. Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: recent insights and future challenges. Cancer Treat. Rev. 48 (2016), 20\u201324.",
                        "@reference-instance-id": "OB2BibRecID-947218089-e524002c9d3e1d1fb67ac664b9d7b4e0-33",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: recent insights and future challenges"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84973644391",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "20",
                                    "@last": "24"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Tartari",
                                    "ce:indexed-name": "Tartari F."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Treat. Rev."
                        },
                        "ce:source-text": "Tartari, F., et al., Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: recent insights and future challenges. Cancer Treat. Rev., 2016. 48: p. 20\u20134."
                    },
                    {
                        "ref-fulltext": "Adams, K.T., Cancer immunotherapies\u2013and their cost\u2013take center stage at ASCO's 2015 annual meeting. Manag. Care, 24:7 (2015), 30\u201332.",
                        "@reference-instance-id": "OB2BibRecID-947218089-56016f6ca46b8c40231127e97148596d-34",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapies\u2013and their cost\u2013take center stage at ASCO's 2015 annual meeting"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84942588462",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "30",
                                    "@last": "32"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "K.T.",
                                "@_fa": "true",
                                "ce:surname": "Adams",
                                "ce:indexed-name": "Adams K.T."
                            }]},
                            "ref-sourcetitle": "Manag. Care"
                        },
                        "ce:source-text": "Adams, K.T., Cancer immunotherapies\u2013and their cost\u2013take center stage at ASCO's 2015 annual meeting. Manag. Care, 2015. 24(7): p. 30\u20132."
                    },
                    {
                        "ref-fulltext": "Lobato Gómez, M., et al. Contributions of the international plant science community to the fight against human infectious diseases \u2013 part 1: epidemic and pandemic diseases. Plant Biotechnol. J. 19:10 (2021), 1901\u20131920.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b6b5a3bb46368b90cc2a9367848ac991-35",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Contributions of the international plant science community to the fight against human infectious diseases \u2013 part 1: epidemic and pandemic diseases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85110534295",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1901",
                                    "@last": "1920"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Lobato Gómez",
                                    "ce:indexed-name": "Lobato Gomez M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Plant Biotechnol. J."
                        },
                        "ce:source-text": "Lobato Gómez, M., et al., Contributions of the international plant science community to the fight against human infectious diseases \u2013 part 1: epidemic and pandemic diseases. Plant Biotechnol. J., 2021. 19(10): p. 1901\u20131920."
                    },
                    {
                        "ref-fulltext": "He, W., et al. Contributions of the international plant science community to the fight against infectious diseases in humans\u2014Part 2: affordable drugs in edible plants for endemic and re-emerging diseases. Plant Biotechnol. J. 19:10 (2021), 1921\u20131936.",
                        "@reference-instance-id": "OB2BibRecID-947218089-007deab673e9b92a80f3af913b0d694c-36",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Contributions of the international plant science community to the fight against infectious diseases in humans\u2014Part 2: affordable drugs in edible plants for endemic and re-emerging diseases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85110459564",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1921",
                                    "@last": "1936"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "He",
                                    "ce:indexed-name": "He W."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Plant Biotechnol. J."
                        },
                        "ce:source-text": "He, W., et al., Contributions of the international plant science community to the fight against infectious diseases in humans\u2014Part 2: affordable drugs in edible plants for endemic and re-emerging diseases. Plant Biotechnol. J., 2021. 19(10): p. 1921\u20131936."
                    },
                    {
                        "ref-fulltext": "Siriwattananon, K., et al. Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2. Front. Plant Sci., 11, 2020, 604663.",
                        "@reference-instance-id": "OB2BibRecID-947218089-87b7c8445edc4f7299b6448b2f010cd7-37",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "604663",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85099723203",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "11"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Siriwattananon",
                                    "ce:indexed-name": "Siriwattananon K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front. Plant Sci."
                        },
                        "ce:source-text": "Siriwattananon, K., et al., Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2. Front. Plant Sci., 2020. 11: p. 604663."
                    },
                    {
                        "ref-fulltext": "Rattanapisit, K., et al. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana. Sci. Rep., 10(1), 2020, 17698.",
                        "@reference-instance-id": "OB2BibRecID-947218089-5955516a52611bb98dd51bf0db1dc72e-38",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092784787",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "17698"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Rattanapisit",
                                    "ce:indexed-name": "Rattanapisit K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Rattanapisit, K., et al., Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana. Sci. Rep., 2020. 10(1): p. 17698."
                    },
                    {
                        "ref-fulltext": "Yiemchavee, S., et al. Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy. J. Biotechnol. 329 (2021), 29\u201337.",
                        "@reference-instance-id": "OB2BibRecID-947218089-cd5393f0f9c52468e761df419705372b-39",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100469086",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "329"},
                                "pagerange": {
                                    "@first": "29",
                                    "@last": "37"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Yiemchavee",
                                    "ce:indexed-name": "Yiemchavee S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Biotechnol."
                        },
                        "ce:source-text": "Yiemchavee, S., et al., Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer immunotherapy. J. Biotechnol., 2021. 329: p. 29\u201337."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., et al. Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity. Vaccine 40:32 (2022), 4440\u20134452.",
                        "@reference-instance-id": "OB2BibRecID-947218089-6fc5a85ff4a3f4bb310bb18834b16cf2-40",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85131788460",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "32"
                                },
                                "pagerange": {
                                    "@first": "4440",
                                    "@last": "4452"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "Shanmugaraj, B., et al., Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity. Vaccine, 2022. 40(32): p. 4440\u20134452."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., et al. Harnessing the potential of plant expression system towards the production of vaccines for the prevention of human papillomavirus and cervical cancer. Vaccines, 10(12), 2022 (Basel).",
                        "@reference-instance-id": "OB2BibRecID-947218089-dfcac5c5a90eb4703d098ab6d8371593-41",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Harnessing the potential of plant expression system towards the production of vaccines for the prevention of human papillomavirus and cervical cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85144677545",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "10",
                                "@issue": "12"
                            }},
                            "ref-text": "(Basel)",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Vaccines"
                        },
                        "ce:source-text": "Shanmugaraj, B., et al., Harnessing the potential of plant expression system towards the production of vaccines for the prevention of human papillomavirus and cervical cancer. Vaccines (Basel), 2022. 10(12)."
                    },
                    {
                        "ref-fulltext": "Balamurugan, S., et al. Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro. Front Plant Sci, 11(1811), 2020.",
                        "@reference-instance-id": "OB2BibRecID-947218089-be461df3d6adc5b2e74ca573ea579e42-42",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102344838",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "11",
                                "@issue": "1811"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Balamurugan",
                                    "ce:indexed-name": "Balamurugan S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Plant Sci"
                        },
                        "ce:source-text": "Balamurugan, S., et al., Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro. Front Plant Sci, 2020. 11(1811)."
                    },
                    {
                        "ref-fulltext": "Rattanapisit, K., et al. Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody. Sci. Rep., 9(1), 2019, 15205.",
                        "@reference-instance-id": "OB2BibRecID-947218089-19c493b61eab6f3545f5d7f863681cee-43",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074097306",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "15205"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Rattanapisit",
                                    "ce:indexed-name": "Rattanapisit K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Rattanapisit, K., et al., Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody. Sci. Rep., 2019. 9(1): p. 15205."
                    },
                    {
                        "ref-fulltext": "Rattanapisit, K., et al. Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plants, 8(12), 2019 (Basel).",
                        "@reference-instance-id": "OB2BibRecID-947218089-8a9cc59e6d1bafc50ec7127f908275ce-44",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85075992522",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "8",
                                "@issue": "12"
                            }},
                            "ref-text": "(Basel)",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Rattanapisit",
                                    "ce:indexed-name": "Rattanapisit K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Plants"
                        },
                        "ce:source-text": "Rattanapisit, K., et al., Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plants (Basel), 2019. 8(12)."
                    },
                    {
                        "ref-fulltext": "Davis, K., et al. Nicotiana benthamiana as a transient expression host to produce auxin analogs. Front. Plant. Sci., 11(1791), 2020.",
                        "@reference-instance-id": "OB2BibRecID-947218089-112112adef7bcc8a5eb400cd73a116f2-45",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Nicotiana benthamiana as a transient expression host to produce auxin analogs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85097224886",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "11",
                                "@issue": "1791"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Davis",
                                    "ce:indexed-name": "Davis K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front. Plant. Sci."
                        },
                        "ce:source-text": "Davis, K., et al., Nicotiana benthamiana as a transient expression host to produce auxin analogs. Front. Plant. Sci., 2020. 11(1791)."
                    },
                    {
                        "ref-fulltext": "Bulaon, C.I.J., et al. Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity. Biotechnol. Rep., 27, 2020, e00514.",
                        "@reference-instance-id": "OB2BibRecID-947218089-e45a2b2ddb14bc7eb98bace4db98f898-46",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0046",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089430366",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {"@first": "e00514"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.I.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Bulaon",
                                    "ce:indexed-name": "Bulaon C.I.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biotechnol. Rep."
                        },
                        "ce:source-text": "Bulaon, C.I.J., et al., Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity. Biotechnol. Rep., 2020. 27: p. e00514."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., et al. Biotechnological insights on the expression and production of antimicrobial peptides in plants. Molecules, 26(13), 2021.",
                        "@reference-instance-id": "OB2BibRecID-947218089-5c5ac2c827b77242a353b1633e38a3ce-47",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Biotechnological insights on the expression and production of antimicrobial peptides in plants"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0047",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85110041710",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "26",
                                "@issue": "13"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Molecules"
                        },
                        "ce:source-text": "Shanmugaraj, B., et al., Biotechnological insights on the expression and production of antimicrobial peptides in plants. Molecules, 2021. 26(13)."
                    },
                    {
                        "ref-fulltext": "Rattanapisit, K., et al. Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis. Biomater. Transl. 2:1 (2021), 43\u201349.",
                        "@reference-instance-id": "OB2BibRecID-947218089-4e5c80cfd7b683cf2772e4d23d8083b0-48",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0048",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107044229",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "43",
                                    "@last": "49"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Rattanapisit",
                                    "ce:indexed-name": "Rattanapisit K."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biomater. Transl."
                        },
                        "ce:source-text": "Rattanapisit, K., et al., Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis. Biomater. Transl., 2021. 2(1): p. 43\u201349."
                    },
                    {
                        "ref-fulltext": "Tschofen, M., et al. Plant molecular farming: much more than medicines. Annu. Rev. Anal. Chem. 9:1 (2016), 271\u2013294 (Palo Alto Calif).",
                        "@reference-instance-id": "OB2BibRecID-947218089-547337dfdaa196a36cf73bb6e99b2d23-49",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Plant molecular farming: much more than medicines"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0049",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84975469462",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "271",
                                    "@last": "294"
                                }
                            },
                            "ref-text": "(Palo Alto Calif)",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Tschofen",
                                    "ce:indexed-name": "Tschofen M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Annu. Rev. Anal. Chem."
                        },
                        "ce:source-text": "Tschofen, M., et al., Plant molecular farming: much more than medicines. Annu. Rev. Anal. Chem. (Palo Alto Calif), 2016. 9(1): p. 271\u201394."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., Bulaon, C.J.I, Phoolcharoen, W., Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants, 9(7), 2020, 842 (Basel, Switzerland).",
                        "@reference-instance-id": "OB2BibRecID-947218089-0ea86da68f03ccb64a056cfb045afde5-50",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Plant molecular farming: a viable platform for recombinant biopharmaceutical production"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0050",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089441197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "7"
                                },
                                "pagerange": {"@first": "842"}
                            },
                            "ref-text": "(Basel, Switzerland)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                },
                                {
                                    "ce:given-name": "C.J.I",
                                    "@seq": "2",
                                    "ce:initials": "C.J.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Bulaon",
                                    "ce:indexed-name": "Bulaon C.J.I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Phoolcharoen",
                                    "ce:indexed-name": "Phoolcharoen W."
                                }
                            ]},
                            "ref-sourcetitle": "Plants"
                        },
                        "ce:source-text": "Shanmugaraj, B., C.J.I Bulaon, and W. Phoolcharoen, Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants (Basel, Switzerland), 2020. 9(7): p. 842."
                    },
                    {
                        "ref-fulltext": "Murad, S., et al. Molecular pharming for low and middle income countries. Curr. Opin. Biotechnol. 61 (2020), 53\u201359.",
                        "@reference-instance-id": "OB2BibRecID-947218089-11ab3d319d0aea59dc00b36ec4eb7a1b-51",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Molecular pharming for low and middle income countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0051",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074994662",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "53",
                                    "@last": "59"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Murad",
                                    "ce:indexed-name": "Murad S."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr. Opin. Biotechnol."
                        },
                        "ce:source-text": "Murad, S., et al., Molecular pharming for low and middle income countries. Curr. Opin. Biotechnol., 2020. 61: p. 53\u201359."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., Ramalingam, S., Plant Expression platform for the production of recombinant pharmaceutical proteins. Austin J. Biotechnol. Bioeng., 1(4), 2014, 4.",
                        "@reference-instance-id": "OB2BibRecID-947218089-a3165fa706c3910eff153750da9efd6e-52",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Plant Expression platform for the production of recombinant pharmaceutical proteins"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0052",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85002661543",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "1",
                                    "@issue": "4"
                                },
                                "pagerange": {"@first": "4"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramalingam",
                                    "ce:indexed-name": "Ramalingam S."
                                }
                            ]},
                            "ref-sourcetitle": "Austin J. Biotechnol. Bioeng."
                        },
                        "ce:source-text": "Shanmugaraj, B. and S. Ramalingam, Plant Expression platform for the production of recombinant pharmaceutical proteins. Austin J. Biotechnol. Bioeng., 2014. 1(4): p. 4."
                    },
                    {
                        "ref-fulltext": "Chen, Q., Davisa, K.R., The potential of plants as a system for the development and production of human biologics. F1000, 5(912), 2016 Faculty Rev.",
                        "@reference-instance-id": "OB2BibRecID-947218089-17d2f325780a8f384f4cbc155e8cf06c-53",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The potential of plants as a system for the development and production of human biologics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0053",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85015651201",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "5",
                                "@issue": "912"
                            }},
                            "ref-text": "Faculty Rev",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Q.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen Q."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Davisa",
                                    "ce:indexed-name": "Davisa K.R."
                                }
                            ]},
                            "ref-sourcetitle": "F1000"
                        },
                        "ce:source-text": "Chen, Q. and K.R. Davisa, The potential of plants as a system for the development and production of human biologics. F1000 Faculty Rev, 2016. 5(912)."
                    },
                    {
                        "ref-fulltext": "Mammedov, T. and N. Gun, Post-translational modifications of recombinant proteins produced in plants: review. 2022. 5: p. 154\u2013161.",
                        "@reference-instance-id": "OB2BibRecID-947218089-24bc0a43218e34d5b8769c46741b4e8a-54",
                        "@id": "54",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0054",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151290904",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "154",
                                "@last": "161"
                            }},
                            "ref-text": "Post-translational modifications of recombinant proteins produced in plants: review. 2022. 5:",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Mammedov",
                                    "ce:indexed-name": "Mammedov T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Gun",
                                    "ce:indexed-name": "Gun N."
                                }
                            ]}
                        },
                        "ce:source-text": "Mammedov, T. and N. Gun, Post-translational modifications of recombinant proteins produced in plants: review. 2022. 5: p. 154\u2013161."
                    },
                    {
                        "ref-fulltext": "Burnett, M.J.B. and A.C. Burnett, Therapeutic recombinant protein production in plants: challenges and opportunities. 2020. 2(2): p. 121\u2013132.",
                        "@reference-instance-id": "OB2BibRecID-947218089-419e4cda88cb30f31dffa0ba3255a97b-55",
                        "@id": "55",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0055",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151283075",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "121",
                                "@last": "132"
                            }},
                            "ref-text": "Therapeutic recombinant protein production in plants: challenges and opportunities. 2020. 2(2):",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.J.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Burnett",
                                    "ce:indexed-name": "Burnett M.J.B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Burnett",
                                    "ce:indexed-name": "Burnett A.C."
                                }
                            ]}
                        },
                        "ce:source-text": "Burnett, M.J.B. and A.C. Burnett, Therapeutic recombinant protein production in plants: challenges and opportunities. 2020. 2(2): p. 121\u2013132."
                    },
                    {
                        "ref-fulltext": "Shanmugaraj, B., Bulaon, C.J.I., Phoolcharoen, W., Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants, 9(7), 2020 (Basel).",
                        "@reference-instance-id": "OB2BibRecID-947218089-9221de5cb6e02f34a8ddf749ec8cde99-56",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Plant molecular farming: a viable platform for recombinant biopharmaceutical production"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0056",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85089441197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "9",
                                "@issue": "7"
                            }},
                            "ref-text": "(Basel)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Shanmugaraj",
                                    "ce:indexed-name": "Shanmugaraj B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.J.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Bulaon",
                                    "ce:indexed-name": "Bulaon C.J.I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Phoolcharoen",
                                    "ce:indexed-name": "Phoolcharoen W."
                                }
                            ]},
                            "ref-sourcetitle": "Plants"
                        },
                        "ce:source-text": "Shanmugaraj, B., C.J.I. Bulaon, and W. Phoolcharoen, Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants (Basel), 2020. 9(7)."
                    },
                    {
                        "ref-fulltext": "Strasser, R., et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6:4 (2008), 392\u2013402.",
                        "@reference-instance-id": "OB2BibRecID-947218089-9212c7ff2781177c5a4d5f39f52b804e-57",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0057",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "41749105290",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "392",
                                    "@last": "402"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Strasser",
                                    "ce:indexed-name": "Strasser R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Plant Biotechnol. J."
                        },
                        "ce:source-text": "Strasser, R., et al., Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J., 2008. 6(4): p. 392\u2013402."
                    },
                    {
                        "ref-fulltext": "Montero-Morales, L., Steinkellner, H., Advanced plant-based glycan engineering. Front. Bioeng. Biotechnol., 6, 2018, 81.",
                        "@reference-instance-id": "OB2BibRecID-947218089-8a2225335ff1b29cedf6d71bce6ba523-58",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Advanced plant-based glycan engineering"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0058",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048781757",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "81"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Montero-Morales",
                                    "ce:indexed-name": "Montero-Morales L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Steinkellner",
                                    "ce:indexed-name": "Steinkellner H."
                                }
                            ]},
                            "ref-sourcetitle": "Front. Bioeng. Biotechnol."
                        },
                        "ce:source-text": "Montero-Morales, L. and H. Steinkellner, Advanced plant-based glycan engineering. Front. Bioeng. Biotechnol., 2018. 6: p. 81."
                    },
                    {
                        "ref-fulltext": "Efremova, M., et al. Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nat. Commun., 9(1), 2018, 32.",
                        "@reference-instance-id": "OB2BibRecID-947218089-e864124a847ddcbc4032924244af9840-59",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0059",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85039965488",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "32"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Efremova",
                                    "ce:indexed-name": "Efremova M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat. Commun."
                        },
                        "ce:source-text": "Efremova, M., et al., Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nat. Commun., 2018. 9(1): p. 32."
                    },
                    {
                        "ref-fulltext": "Denis, M., et al. Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy. Front. Immunol., 13, 2023.",
                        "@reference-instance-id": "OB2BibRecID-947218089-541151730118f490a99fa390fdafde64-60",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0060",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85146940564",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "13"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Denis",
                                    "ce:indexed-name": "Denis M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front. Immunol."
                        },
                        "ce:source-text": "Denis, M., et al., Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy. Front. Immunol., 2023. 13."
                    },
                    {
                        "ref-fulltext": "Jin, Y., et al. Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Sci. Rep., 12(1), 2022, 3278.",
                        "@reference-instance-id": "OB2BibRecID-947218089-84f686280ca0f7b0d2227438f83c52ca-61",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0061",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85125599818",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "3278"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Jin",
                                    "ce:indexed-name": "Jin Y."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci. Rep."
                        },
                        "ce:source-text": "Jin, Y., et al., Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Sci. Rep., 2022. 12(1): p. 3278."
                    },
                    {
                        "ref-fulltext": "Seidel, J.A., Otsuka, A., Kabashima, K., Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations. Front. Oncol., 8, 2018, 86.",
                        "@reference-instance-id": "OB2BibRecID-947218089-1b1e6fdca84f62fdee55a2fe6574c714-62",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0062",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044932853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "86"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Seidel",
                                    "ce:indexed-name": "Seidel J.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Otsuka",
                                    "ce:indexed-name": "Otsuka A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kabashima",
                                    "ce:indexed-name": "Kabashima K."
                                }
                            ]},
                            "ref-sourcetitle": "Front. Oncol."
                        },
                        "ce:source-text": "Seidel, J.A., A. Otsuka, and K. Kabashima, Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations. Front. Oncol., 2018. 8: p. 86."
                    },
                    {
                        "ref-fulltext": "Wolchok, J.D., et al. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann. N. Y. Acad. Sci. 1291:1 (2013), 1\u201313.",
                        "@reference-instance-id": "OB2BibRecID-947218089-a5330d105e860794fa4a49b46aa47767-63",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0063",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84880511594",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "1291",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "13"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolchok",
                                    "ce:indexed-name": "Wolchok J.D."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann. N. Y. Acad. Sci."
                        },
                        "ce:source-text": "Wolchok, J.D., et al., Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann. N. Y. Acad. Sci., 2013. 1291(1): p. 1\u201313."
                    },
                    {
                        "ref-fulltext": "Pons-Tostivint, E., et al., Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of Phase III trials. 2019(3): p. 1\u201310.",
                        "@reference-instance-id": "OB2BibRecID-947218089-55d7327d3cd69e00418366d8999d202c-64",
                        "@id": "64",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0064",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85151258931",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "1",
                                "@last": "10"
                            }},
                            "ref-text": "Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of Phase III trials. 2019(3):",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Pons-Tostivint",
                                    "ce:indexed-name": "Pons-Tostivint E."
                                }],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Pons-Tostivint, E., et al., Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of Phase III trials. 2019(3): p. 1\u201310."
                    },
                    {
                        "ref-fulltext": "Barber, D.L., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:7077 (2006), 682\u2013687.",
                        "@reference-instance-id": "OB2BibRecID-947218089-3eb102ea7ebd15fb604678413df65fda-65",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Restoring function in exhausted CD8 T cells during chronic viral infection"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0065",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "32544459770",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "439",
                                    "@issue": "7077"
                                },
                                "pagerange": {
                                    "@first": "682",
                                    "@last": "687"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "D.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Barber",
                                    "ce:indexed-name": "Barber D.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Barber, D.L., et al., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 2006. 439(7077): p. 682\u20137."
                    },
                    {
                        "ref-fulltext": "Garcia-Diaz, A., et al. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 19:6 (2017), 1189\u20131201.",
                        "@reference-instance-id": "OB2BibRecID-947218089-9b17e0aa117e1b207325c6326cc484a9-66",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0066",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019192700",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1189",
                                    "@last": "1201"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Garcia-Diaz",
                                    "ce:indexed-name": "Garcia-Diaz A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell Rep."
                        },
                        "ce:source-text": "Garcia-Diaz, A., et al., Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep., 2017. 19(6): p. 1189\u20131201."
                    },
                    {
                        "ref-fulltext": "Velcheti, V., et al. Programmed death ligand-1 expression in non-small cell lung cancer. Lab. Investig. 94:1 (2014), 107\u2013116.",
                        "@reference-instance-id": "OB2BibRecID-947218089-84df0ab0a4ac324bfac7e527bdc633f1-67",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Programmed death ligand-1 expression in non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0067",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891534246",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "94",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "116"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Velcheti",
                                    "ce:indexed-name": "Velcheti V."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lab. Investig."
                        },
                        "ce:source-text": "Velcheti, V., et al., Programmed death ligand-1 expression in non-small cell lung cancer. Lab. Investig., 2014. 94(1): p. 107\u201316."
                    },
                    {
                        "ref-fulltext": "Wei, S.C., et al. Distinct cellular mechanisms underlie anti-CTLA-4 and Anti-PD-1 checkpoint blockade. Cell, 170(6), 2017 1120-1133.e17.",
                        "@reference-instance-id": "OB2BibRecID-947218089-ea2fce04916d83fd2c336898ebc513a7-68",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Distinct cellular mechanisms underlie anti-CTLA-4 and Anti-PD-1 checkpoint blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0068",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85028060533",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "170",
                                "@issue": "6"
                            }},
                            "ref-text": "1120-1133.e17",
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Wei",
                                    "ce:indexed-name": "Wei S.C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Wei, S.C., et al., Distinct cellular mechanisms underlie anti-CTLA-4 and Anti-PD-1 checkpoint blockade. Cell, 2017. 170(6): p. 1120-1133.e17."
                    },
                    {
                        "ref-fulltext": "Robert, C., et al. Pembrolizumab versus Ipilimumab in advanced melanoma. N. Engl. J. Med. 372:26 (2015), 2521\u20132532.",
                        "@reference-instance-id": "OB2BibRecID-947218089-af1d6dd07961c483cf4c0e4f7dc8b9fc-69",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pembrolizumab versus Ipilimumab in advanced melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0069",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929481481",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "372",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2521",
                                    "@last": "2532"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Robert",
                                    "ce:indexed-name": "Robert C."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Robert, C., et al., Pembrolizumab versus Ipilimumab in advanced melanoma. N. Engl. J. Med., 2015. 372(26): p. 2521\u201332."
                    },
                    {
                        "ref-fulltext": "Chow, L.Q.M., et al. Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort. J. Clin. Oncol. 34:32 (2016), 3838\u20133845.",
                        "@reference-instance-id": "OB2BibRecID-947218089-7241f5ebf5b0eab63d5c21224c81c934-70",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0070",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84995489253",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "34",
                                    "@issue": "32"
                                },
                                "pagerange": {
                                    "@first": "3838",
                                    "@last": "3845"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "L.Q.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Chow",
                                    "ce:indexed-name": "Chow L.Q.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Chow, L.Q.M., et al., Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort. J. Clin. Oncol., 2016. 34(32): p. 3838\u20133845."
                    },
                    {
                        "ref-fulltext": "Powles, T., et al. Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1/2 open-label study. JAMA Oncol., 3(9), 2017, e172411.",
                        "@reference-instance-id": "OB2BibRecID-947218089-6226e5864b4dfcb57d782f6127f6ee57-71",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1/2 open-label study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0071",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e172411",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85030424068",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "3",
                                "@issue": "9"
                            }},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Powles",
                                    "ce:indexed-name": "Powles T."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol."
                        },
                        "ce:source-text": "Powles, T., et al., Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1/2 open-label study. JAMA Oncol., 2017. 3(9): p. e172411."
                    },
                    {
                        "ref-fulltext": "Akinleye, A., Rasool, Z., Immune checkpoint inhibitors of PD-L1 as cancer therapeutics. J. Hematol. Oncol., 12(1), 2019, 92.",
                        "@reference-instance-id": "OB2BibRecID-947218089-4af3048e0e0cff700841a9fbfac271a7-72",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitors of PD-L1 as cancer therapeutics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0072",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071736703",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "92"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Akinleye",
                                    "ce:indexed-name": "Akinleye A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Rasool",
                                    "ce:indexed-name": "Rasool Z."
                                }
                            ]},
                            "ref-sourcetitle": "J. Hematol. Oncol."
                        },
                        "ce:source-text": "Akinleye, A. and Z. Rasool, Immune checkpoint inhibitors of PD-L1 as cancer therapeutics. J. Hematol. Oncol., 2019. 12(1): p. 92."
                    },
                    {
                        "ref-fulltext": "Dantoing, E., et al. Anti-PD1/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations. Int. J. Mol. Sci., 22(12), 2021, 6288.",
                        "@reference-instance-id": "OB2BibRecID-947218089-ffb25cde5f4b4eb4649fbe662f57e70c-73",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Anti-PD1/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0073",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85107473936",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "12"
                                },
                                "pagerange": {"@first": "6288"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Dantoing",
                                    "ce:indexed-name": "Dantoing E."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int. J. Mol. Sci."
                        },
                        "ce:source-text": "Dantoing, E., et al., Anti-PD1/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations. Int. J. Mol. Sci., 2021. 22(12): p. 6288."
                    },
                    {
                        "ref-fulltext": "Brahmer, J.R., et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28:19 (2010), 3167\u20133175.",
                        "@reference-instance-id": "OB2BibRecID-947218089-424aea956376cfd20269e63c3e73080c-74",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0074",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77954899030",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "3167",
                                    "@last": "3175"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Brahmer",
                                    "ce:indexed-name": "Brahmer J.R."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Brahmer, J.R., et al., Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol., 2010. 28(19): p. 3167\u201375."
                    },
                    {
                        "ref-fulltext": "Topalian, S.L., et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366:26 (2012), 2443\u20132454.",
                        "@reference-instance-id": "OB2BibRecID-947218089-805759f28e48725197daa021f90b1ed0-75",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0075",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84862859820",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "366",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2443",
                                    "@last": "2454"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Topalian",
                                    "ce:indexed-name": "Topalian S.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Topalian, S.L., et al., Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med., 2012. 366(26): p. 2443\u201354."
                    },
                    {
                        "ref-fulltext": "Topalian, S.L., et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J. Clin. Oncol. 32:10 (2014), 1020\u20131030.",
                        "@reference-instance-id": "OB2BibRecID-947218089-0a0562f399bff5b3c53d27f75f495a5a-76",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0076",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84898973055",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1020",
                                    "@last": "1030"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Topalian",
                                    "ce:indexed-name": "Topalian S.L."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Clin. Oncol."
                        },
                        "ce:source-text": "Topalian, S.L., et al., Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J. Clin. Oncol., 2014. 32(10): p. 1020\u201330."
                    },
                    {
                        "ref-fulltext": "Ansell, S.M., et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N. Engl. J. Med. 372:4 (2015), 311\u2013319.",
                        "@reference-instance-id": "OB2BibRecID-947218089-192ce2677deb4d88de8571264c1ac812-77",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0077",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925221855",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "372",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "311",
                                    "@last": "319"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "S.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Ansell",
                                    "ce:indexed-name": "Ansell S.M."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N. Engl. J. Med."
                        },
                        "ce:source-text": "Ansell, S.M., et al., PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N. Engl. J. Med., 2015. 372(4): p. 311\u20139."
                    },
                    {
                        "ref-fulltext": "Escudier, B., et al. CheckMate 025 randomized phase 3 study: outcomes by key baseline factors and prior therapy for Nivolumab versus Everolimus in advanced renal cell carcinoma. Eur. Urol. 72:6 (2017), 962\u2013971.",
                        "@reference-instance-id": "OB2BibRecID-947218089-271c2e58f2a485490b7acdd8e3d56d84-78",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "CheckMate 025 randomized phase 3 study: outcomes by key baseline factors and prior therapy for Nivolumab versus Everolimus in advanced renal cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0078",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85014412019",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "962",
                                    "@last": "971"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Escudier",
                                    "ce:indexed-name": "Escudier B."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur. Urol."
                        },
                        "ce:source-text": "Escudier, B., et al., CheckMate 025 randomized phase 3 study: outcomes by key baseline factors and prior therapy for Nivolumab versus Everolimus in advanced renal cell carcinoma. Eur. Urol., 2017. 72(6): p. 962\u2013971."
                    },
                    {
                        "ref-fulltext": "Motzer, R.J., et al. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. Lancet Oncol. 20:10 (2019), 1370\u20131385.",
                        "@reference-instance-id": "OB2BibRecID-947218089-17c4871e7be040492b24812eaeab46b9-79",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0079",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072673151",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1370",
                                    "@last": "1385"
                                }
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "R.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Motzer",
                                    "ce:indexed-name": "Motzer R.J."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol."
                        },
                        "ce:source-text": "Motzer, R.J., et al., Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. Lancet Oncol., 2019. 20(10): p. 1370\u20131385."
                    },
                    {
                        "ref-fulltext": "Chen, L., Han, X., Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J. Clin. Investig. 125:9 (2015), 3384\u20133391.",
                        "@reference-instance-id": "OB2BibRecID-947218089-5c4148d7797ac59afb9a7e2dee89e68e-80",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0080",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84941711371",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "125",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "3384",
                                    "@last": "3391"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Han",
                                    "ce:indexed-name": "Han X."
                                }
                            ]},
                            "ref-sourcetitle": "J. Clin. Investig."
                        },
                        "ce:source-text": "Chen, L. and X. Han, Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J. Clin. Investig., 2015. 125(9): p. 3384\u20133391."
                    },
                    {
                        "ref-fulltext": "Chen, L., Co-inhibitory molecules of the B7\u2013CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4:5 (2004), 336\u2013347.",
                        "@reference-instance-id": "OB2BibRecID-947218089-946f6ef022eefee1e048aedcac83ea91-81",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Co-inhibitory molecules of the B7\u2013CD28 family in the control of T-cell immunity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0081",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2442585121",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "336",
                                    "@last": "347"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen L."
                            }]},
                            "ref-sourcetitle": "Nat. Rev. Immunol."
                        },
                        "ce:source-text": "Chen, L., Co-inhibitory molecules of the B7\u2013CD28 family in the control of T-cell immunity. Nat. Rev. Immunol., 2004. 4(5): p. 336\u2013347."
                    },
                    {
                        "ref-fulltext": "Capasso, A., et al. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. J. Immunother. Cancer, 7(1), 2019, 37.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b61f05ce32a9a407138aea54b6b9ebe4-82",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0082",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85061278561",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "37"}
                            },
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Capasso",
                                    "ce:indexed-name": "Capasso A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J. Immunother. Cancer"
                        },
                        "ce:source-text": "Capasso, A., et al., Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. J. Immunother. Cancer, 2019. 7(1): p. 37."
                    },
                    {
                        "ref-fulltext": "Weaver, J.A., et al. Hazards of diethyl phthalate (DEP) exposure: a systematic review of animal toxicology studies. Environ. Int., 145, 2020, 105848.",
                        "@reference-instance-id": "OB2BibRecID-947218089-b61f86315d2146726793ec421b22eb2d-83",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Hazards of diethyl phthalate (DEP) exposure: a systematic review of animal toxicology studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib0083",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "105848",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85091229883",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "145"}},
                            "ref-authors": {
                                "author": [{
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Weaver",
                                    "ce:indexed-name": "Weaver J.A."
                                }],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Environ. Int."
                        },
                        "ce:source-text": "Weaver, J.A., et al., Hazards of diethyl phthalate (DEP) exposure: a systematic review of animal toxicology studies. Environ. Int., 2020. 145: p. 105848."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "126563806",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126563806",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "126194184",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126194184",
            "affiliation-country": "China"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85151297119",
        "dc:description": "The therapeutic blockade of inhibitory PD-1 signaling has emerged as an effective approach for cancer immunotherapy. Nivolumab (Opdivo®), a monoclonal antibody (mAb) targeting the PD-1 immune checkpoint, is approved for treatment of several cancer indications. It functions by blocking the PD-1-mediated T-cell inhibition thus reinstating anticancer immune responses. Tremendous advances in plant biotechnology offer an alternative and economical strategy to produce therapeutic mAbs for immune-based therapies. In this study, recombinant anti-PD-1 Nivolumab was produced in Nicotiana benthamiana and the plant-produced anti-PD-1 mAb was exploited for cancer treatment in syngeneic mice model C57BL/6 mice that were used to test the antitumor efficacy of plant produced Nivolumab, along with commercial Opdivo®. C57BL/6 syngeneic mice treated with plant produced anti-PD-1 mAb exhibited reduction in the growth of established MC38 tumors. The plant produced Nivolumab treatment showed 82.9% antitumor effect in decreasing the tumor volume along with 50% tumor-free mice, whereas Opdivo® showed 90.26% reduction in volume without any tumor-free mice. Finally, plant-derived anti-PD-1 therapy was also well tolerated in tumor-bearing mice that correlated with no significant body weight changes. Overall, our plant-produced Nivolumab elicits significant inhibition of tumor growth in vivo and provides a proof-of-concept for the production of immunotherapy targeting PD-1.",
        "prism:coverDate": "2023-06-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85151297119",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Christine Joy I.",
            "preferred-name": {
                "ce:given-name": "Christine Joy I.",
                "ce:initials": "C.J.I.",
                "ce:surname": "Bulaon",
                "ce:indexed-name": "Bulaon C.J.I."
            },
            "@seq": "1",
            "ce:initials": "C.J.I.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Bulaon",
            "@auid": "57218530325",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218530325",
            "ce:indexed-name": "Bulaon C.J.I."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85151297119"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85151297119&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85151297119&origin=inward"
            }
        ],
        "prism:publicationName": "Biotechnology Reports",
        "source-id": "21100324971",
        "pii": "S2215017X23000140",
        "citedby-count": "0",
        "prism:volume": "38",
        "subtype": "ar",
        "dc:title": "Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL/6-hPD-1 mouse implanted with MC38 colon cancer",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.btre.2023.e00794",
        "prism:issn": "2215017X",
        "publishercopyright": "© 2023",
        "article-number": "e00794",
        "dc:identifier": "SCOPUS_ID:85151297119",
        "dc:publisher": "Elsevier B.V."
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Antitumor"
        },
        {
            "@_fa": "true",
            "$": "Immuno-oncology"
        },
        {
            "@_fa": "true",
            "$": "Immunomodulators"
        },
        {
            "@_fa": "true",
            "$": "Nivolumab"
        },
        {
            "@_fa": "true",
            "$": "PD-1"
        },
        {
            "@_fa": "true",
            "$": "Programmed cell death"
        },
        {
            "@_fa": "true",
            "$": "Protein therapeutics"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Biotechnology",
            "@code": "1305",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Applied Microbiology and Biotechnology",
            "@code": "2402",
            "@abbrev": "IMMU"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Christine Joy I.",
            "preferred-name": {
                "ce:given-name": "Christine Joy I.",
                "ce:initials": "C.J.I.",
                "ce:surname": "Bulaon",
                "ce:indexed-name": "Bulaon C.J.I."
            },
            "@seq": "1",
            "ce:initials": "C.J.I.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Bulaon",
            "@auid": "57218530325",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218530325",
            "ce:indexed-name": "Bulaon C.J.I."
        },
        {
            "ce:given-name": "Hongyan",
            "preferred-name": {
                "ce:given-name": "Hongyan",
                "ce:initials": "H.",
                "ce:surname": "Sun",
                "ce:indexed-name": "Sun H."
            },
            "@seq": "2",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126194184",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126194184"
            },
            "ce:surname": "Sun",
            "@auid": "58164414400",
            "author-url": "https://api.elsevier.com/content/author/author_id/58164414400",
            "ce:indexed-name": "Sun H."
        },
        {
            "ce:given-name": "Ashwini",
            "preferred-name": {
                "ce:given-name": "Ashwini",
                "ce:initials": "A.",
                "ce:surname": "Malla",
                "ce:indexed-name": "Malla A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "126563806",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126563806"
            },
            "ce:surname": "Malla",
            "@auid": "57014728200",
            "author-url": "https://api.elsevier.com/content/author/author_id/57014728200",
            "ce:indexed-name": "Malla A."
        },
        {
            "ce:given-name": "Waranyoo",
            "preferred-name": {
                "ce:given-name": "Waranyoo",
                "ce:initials": "W.",
                "ce:surname": "Phoolcharoen",
                "ce:indexed-name": "Phoolcharoen W."
            },
            "@seq": "4",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:surname": "Phoolcharoen",
            "@auid": "26531746600",
            "author-url": "https://api.elsevier.com/content/author/author_id/26531746600",
            "ce:indexed-name": "Phoolcharoen W."
        }
    ]}
}}